Literature DB >> 22520473

Hematopoietic prostaglandin D synthase inhibitors.

Sukanthini Thurairatnam1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22520473     DOI: 10.1016/B978-0-12-396493-9.00004-2

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


× No keyword cloud information.
  6 in total

Review 1.  PROTACs: great opportunities for academia and industry (an update from 2020 to 2021).

Authors:  Ming He; Chaoguo Cao; Zhihao Ni; Yongbo Liu; Peilu Song; Shuang Hao; Yuna He; Xiuyun Sun; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2022-06-09

2.  Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer.

Authors:  Hidetomo Yokoo; Norihito Shibata; Miyako Naganuma; Yuki Murakami; Kiyonaga Fujii; Takahito Ito; Kosuke Aritake; Mikihiko Naito; Yosuke Demizu
Journal:  ACS Med Chem Lett       Date:  2021-01-14       Impact factor: 4.345

Review 3.  Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets.

Authors:  Miriam Peinhaupt; Eva M Sturm; Akos Heinemann
Journal:  Front Med (Lausanne)       Date:  2017-07-19

4.  In vivo and in vitro inhibition of rat liver glutathione transferases activity by extracts from Combretum zeyheri (Combretaceae) and Parinari curatellifolia (Chrysobalanaceae).

Authors:  David Gweshelo; Rudo Muswe; Stanley Mukanganyama
Journal:  BMC Complement Altern Med       Date:  2016-07-25       Impact factor: 3.659

5.  Prostaglandin D2 signaling is not involved in the recovery of rat hind limb tendons from injury.

Authors:  Dylan C Sarver; Kristoffer B Sugg; Jeffrey R Talarek; Jacob B Swanson; David J Oliver; Aaron C Hinken; Henning F Kramer; Christopher L Mendias
Journal:  Physiol Rep       Date:  2019-11

Review 6.  Fragment-based drug discovery: opportunities for organic synthesis.

Authors:  Jeffrey D St Denis; Richard J Hall; Christopher W Murray; Tom D Heightman; David C Rees
Journal:  RSC Med Chem       Date:  2020-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.